Literature DB >> 9861318

Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.

A Tabarin1, F Laurent, B Catargi, F Olivier-Puel, R Lescene, J Berge, F S Galli, J Drouillard, P Roger, J Guerin.   

Abstract

OBJECTIVES: The ability of MRI to detect pituitary ACTH-secreting adenomas in patients with Cushing's disease is limited. Owing to different dynamics of contrast enhancement between adenomas and normal pituitary tissue, it has been suggested that obtaining images within seconds after gadolinium (Gad) injection using dynamic procedures increases the sensitivity of MRI in the detection of pituitary microadenomas. The objective of this study was to compare the ability of conventional magnetic resonance imaging (CMRI) and dynamic MRI (DMRI) to detect ACTH-secreting pituitary adenomas.
DESIGN: Twenty-six consecutive patients with ACTH-dependent Cushing's syndrome and 10 normal subjects were investigated. According to the results of inferior petrosal sinus sampling, 21 patients had Cushing's disease and five had ectopic ACTH syndrome. Patients with Cushing's disease were operated regardless of the results of imaging studies. All underwent identical MRI and DMRI procedures using a 1.0 T magnet. Image sampling time during DMRI was 19 sec. Scans were randomly mixed and analysed blind, retrospectively and independently by two experienced radiologists. The clarity of the images was assessed by the analysis of agreement among radiologists. MRI findings were compared to surgical and histopathological findings.
RESULTS: Surgical exploration identified three macrodenomas and 14 microadenomas. One microadenoma was found at pathological examination after subtotal hypophysectomy and no tumour was found in three cases. According to the combined opinion of radiologists, the three macroadenomas were identified equally well with CMRI and DMRI. Eight ACTH-secreting microadenomas were detected with CMRI and 11 with DMRI. The three microadenomas detected with DMRI only were visualized within 60 sec following Gad injection. No false positives occurred with CMRI. Three false positives were obtained with DMRI: one in a patient with ectopic ACTH syndrome while a silent microprolactinoma and normal tissue were found at the site of the radiological abnormality in two patients with Cushing's disease. In our study, the sensitivity of DMRI is greater than that of CMRI (0.67 vs. 0.52) but is associated with a loss in specificity (0.80 vs. 1.00). False positives may result from the increased sensitivity of DMRI which detects incidental pituitary lesions, technical artefacts or lowest clarity of images, as suggested by a lower observer agreement of DMRI (Kappa statistic 0.66 vs. 0.83). Overall, the two MR procedures had equivalent diagnostic power (0.72).
CONCLUSIONS: In our hands, dynamic procedures did not improve the usefulness of MRI in Cushing's syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9861318     DOI: 10.1046/j.1365-2265.1998.00541.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  34 in total

1.  Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas.

Authors:  Han Bee Lee; Sung Tae Kim; Hyung-Jin Kim; Keon Ha Kim; Pyoung Jeon; Hong Sik Byun; Jin Wook Choi
Journal:  Eur Radiol       Date:  2011-09-24       Impact factor: 5.315

Review 2.  Pituitary magnetic resonance imaging in Cushing's disease.

Authors:  Giovanni Vitale; Fabio Tortora; Roberto Baldelli; Francesco Cocchiara; Rosa Maria Paragliola; Emilia Sbardella; Chiara Simeoli; Ferdinando Caranci; Rosario Pivonello; Annamaria Colao
Journal:  Endocrine       Date:  2016-07-19       Impact factor: 3.633

3.  Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease.

Authors:  Matthew B Potts; Jugal K Shah; Annette M Molinaro; Lewis S Blevins; J Blake Tyrrell; Sandeep Kunwar; Christopher F Dowd; Steven W Hetts; Manish K Aghi
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

Review 4.  State of art imaging of the pituitary tumors.

Authors:  Nicholas J Patronas; Chia-Ying Liu
Journal:  J Neurooncol       Date:  2013-12-17       Impact factor: 4.130

5.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

Review 6.  Diagnosis of Cushing's disease.

Authors:  Eleni Daniel; John D C Newell-Price
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

7.  Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.

Authors:  Gautam U Mehta; Blake K Montgomery; Pooja Raghavan; Susmeeta Sharma; Lynnette K Nieman; Nicholas Patronas; Edward H Oldfield; Prashant Chittiboina
Journal:  J Clin Neurosci       Date:  2015-03-29       Impact factor: 1.961

8.  Comparison of Constructive Interference in Steady-State and T1-Weighted MRI Sequence at Detecting Pituitary Adenomas in Cushing's Disease Patients.

Authors:  Min Lang; Ghaith Habboub; Doksu Moon; Abin Bandyopadhyay; Danilo Silva; Laurence Kennedy; Varun R Kshettry; Pablo F Recinos
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-10

9.  Preoperative Lateralization Modalities for Cushing Disease: Is Dynamic Magnetic Resonance Imaging or Cavernous Sinus Sampling More Predictive of Intraoperative Findings?

Authors:  Hai Sun; Chris Yedinak; Alp Ozpinar; Jim Anderson; Aclan Dogan; Johnny Delashaw; Maria Fleseriu
Journal:  J Neurol Surg B Skull Base       Date:  2015-01-21

10.  In vivo manganese MR imaging of calcium influx in spontaneous rat pituitary adenoma.

Authors:  D J Cross; J A Flexman; Y Anzai; T Sasaki; P M Treuting; K R Maravilla; S Minoshima
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.